Customer Testimonials
| Invitrogen is dedicated to partnering with the brightest minds in the world to create innovative tools that help unravel the mysteries of biology and move closer to providing revolutionary therapeutic treatments for the patient. Working closely with our customers to accelerate their innovation process is extremely important to Invitrogen. Our customers have given us solid input that our efforts and dedication truly supports their evolving scientific objectives. Here’s what some of our high profile customers have to say. |
-
-
“Disease research and drug discovery are becoming incredibly complex due to an array of new methods and a focus on increasingly intricate biological systems. Because Invitrogen is building and shaping its offerings around these scientific challenges, we have confidence that the technologies we use will continually support our evolving objectives.”
Marc Vidal, Ph.D., Director, Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts
 |
-
-
“Invitrogen is a critical partner for achieving our mission at the Burnham Institute for Medical Research. Major research institutions like ours have an infinite number of paths to scientific discovery. Therefore, it is important that we partner with the most innovative, creative and responsive suppliers. Invitrogen offers not only cutting-edge products, but also a ground-breaking support system that underlies its significant portfolio of products. Research at the Burnham moves more rapidly because we benefit from Invitrogen’s powerful Web based ordering systems, highly knowledgeable sales representatives and solutions tailored to our protocols.”
Karin Eastham, Chief Operating Officer, Burnham Institute for Medical Research, La Jolla, California
|
-
-
“Many of the next breakthroughs in medicine will come as the result of work done side-by-side with companies like Invitrogen. Through this collaboration we’re matching technology development to specific research needs, creating an environment where science can move forward rapidly.”
Sam Hanash, M.D., Principal Investigator, Fred Hutchinson Cancer Research Center, Seattle, Washington
|
-
“As biotechnology funding increases globally, research technology must correspondingly extend its reach. Working with Invitrogen, we see a company that utilizes its worldwide presence to ensure availability of its products to all regions, and promotes a collaborative atmosphere among its customers that enables new methods and ideas to flourish.”
Fumio Imamoto, Ph.D., Professor of the Laboratory of Molecular Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
|